These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31407832)

  • 1. Targeting a Large Active Site: Structure-Based Design of Nanomolar Inhibitors of Trypanosoma brucei Trypanothione Reductase.
    De Gasparo R; Halgas O; Harangozo D; Kaiser M; Pai EF; Krauth-Siegel RL; Diederich F
    Chemistry; 2019 Sep; 25(49):11416-11421. PubMed ID: 31407832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase.
    Persch E; Bryson S; Todoroff NK; Eberle C; Thelemann J; Dirdjaja N; Kaiser M; Weber M; Derbani H; Brun R; Schneider G; Pai EF; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2014 Aug; 9(8):1880-91. PubMed ID: 24788386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological Evaluation and X-ray Co-crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma.
    De Gasparo R; Brodbeck-Persch E; Bryson S; Hentzen NB; Kaiser M; Pai EF; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2018 May; 13(9):957-967. PubMed ID: 29624890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of Trypanosoma brucei trypanothione reductase: comparative molecular field analysis modeling and structural basis for selective inhibition.
    Ferreira LG; Andricopulo AD
    Future Med Chem; 2013 Oct; 5(15):1753-62. PubMed ID: 24144411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cynaropicrin targets the trypanothione redox system in Trypanosoma brucei.
    Zimmermann S; Oufir M; Leroux A; Krauth-Siegel RL; Becker K; Kaiser M; Brun R; Hamburger M; Adams M
    Bioorg Med Chem; 2013 Nov; 21(22):7202-9. PubMed ID: 24080104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines.
    Khan MO; Austin SE; Chan C; Yin H; Marks D; Vaghjiani SN; Kendrick H; Yardley V; Croft SL; Douglas KT
    J Med Chem; 2000 Aug; 43(16):3148-56. PubMed ID: 10956223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme.
    Turcano L; Battista T; De Haro ET; Missineo A; Alli C; Paonessa G; Colotti G; Harper S; Fiorillo A; Ilari A; Bresciani A
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008339. PubMed ID: 32437349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved inhibitors of trypanothione reductase by combination of motifs: synthesis, inhibitory potency, binding mode, and antiprotozoal activities.
    Eberle C; Lauber BS; Fankhauser D; Kaiser M; Brun R; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2011 Feb; 6(2):292-301. PubMed ID: 21275053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi.
    Jones DC; Ariza A; Chow WH; Oza SL; Fairlamb AH
    Mol Biochem Parasitol; 2010 Jan; 169(1):12-9. PubMed ID: 19747949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections.
    Linciano P; Pozzi C; Iacono LD; di Pisa F; Landi G; Bonucci A; Gul S; Kuzikov M; Ellinger B; Witt G; Santarem N; Baptista C; Franco C; Moraes CB; Müller W; Wittig U; Luciani R; Sesenna A; Quotadamo A; Ferrari S; Pöhner I; Cordeiro-da-Silva A; Mangani S; Costantino L; Costi MP
    J Med Chem; 2019 Apr; 62(8):3989-4012. PubMed ID: 30908048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor.
    Landi G; Linciano P; Tassone G; Costi MP; Mangani S; Pozzi C
    Acta Crystallogr D Struct Biol; 2020 Jun; 76(Pt 6):558-564. PubMed ID: 32496217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei.
    Lu J; Vodnala SK; Gustavsson AL; Gustafsson TN; Sjöberg B; Johansson HA; Kumar S; Tjernberg A; Engman L; Rottenberg ME; Holmgren A
    J Biol Chem; 2013 Sep; 288(38):27456-27468. PubMed ID: 23900839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening.
    Turcano L; Torrente E; Missineo A; Andreini M; Gramiccia M; Di Muccio T; Genovese I; Fiorillo A; Harper S; Bresciani A; Colotti G; Ilari A
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006969. PubMed ID: 30475811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: discovery, synthesis, and characterization of their binding mode by protein crystallography.
    Patterson S; Alphey MS; Jones DC; Shanks EJ; Street IP; Frearson JA; Wyatt PG; Gilbert IH; Fairlamb AH
    J Med Chem; 2011 Oct; 54(19):6514-30. PubMed ID: 21851087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data.
    Vera B; Vázquez K; Mascayano C; Tapia RA; Espinosa V; Soto-Delgado J; Salas CO; Paulino M
    J Biomol Struct Dyn; 2017 Jun; 35(8):1785-1803. PubMed ID: 27232454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis.
    Richardson JL; Nett IR; Jones DC; Abdille MH; Gilbert IH; Fairlamb AH
    ChemMedChem; 2009 Aug; 4(8):1333-40. PubMed ID: 19557801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diaryl sulfide-based inhibitors of trypanothione reductase: inhibition potency, revised binding mode and antiprotozoal activities.
    Stump B; Eberle C; Kaiser M; Brun R; Krauth-Siegel RL; Diederich F
    Org Biomol Chem; 2008 Nov; 6(21):3935-47. PubMed ID: 18931800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiol redox biology of trypanosomatids and potential targets for chemotherapy.
    Leroux AE; Krauth-Siegel RL
    Mol Biochem Parasitol; 2016; 206(1-2):67-74. PubMed ID: 26592324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
    Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
    ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.